US Pre-Market SEC Filings Roundup — August 14, 2026

13-08-2026

Boston Omaha Corp filed an amended Schedule 13D disclosing that it sold 360,000 shares of Sky Harbour Group Corp Class A common stock on August 11, 2026 at $10.00 per share for gross proceeds of $3.6 million. Following the sale and a concurrent issuance of 4,000,000 new shares by the issuer, Boston Omaha's beneficial ownership decreased to 18,699,773 shares (including warrants), representing 40.45% of Class A stock and 21.18% of combined voting power. The filing shows a reduction in the reporting person's stake but still reflects a significant controlling position.

• · The sale was executed pursuant to an effective registration statement under the Securities Act of 1933.
• · The reporting person's beneficial ownership decreased primarily due to the sale of 360,000 shares and the issuer's issuance of 4,000,000 new Class A shares.
• · Boston Omaha Corp holds 10,979,994 shares of Class A Stock directly and 7,719,779 warrant shares.
• · The investment committee of Boston Omaha Corp, consisting of Adam K. Peterson and Joshua P. Weisenburger, makes all investment and voting decisions for the reported securities.
• · No other transactions in Class A Stock were effected by the reporting person in the past 60 days.

13-08-2026

Richard Ian Griffiths filed Amendment No. 11 to Schedule 13D with the SEC on August 13, 2026, reporting a reduction in his beneficial ownership of Silence Therapeutics plc from a prior level to 14,391,498 ordinary shares (7.97% of 180,628,068 outstanding shares). The filing cites significant dilution from an increase in the issuer's share capital and open-market sales of 5,484,320 ADSs between August 10-12, 2026, generating aggregate proceeds of $87.7 million. While the sales reflect a major monetization event, the ownership stake remains substantial at nearly 8%.

• · The filing is Amendment No. 11, originally filed June 15, 2022, with multiple prior amendments.
• · Mr. Griffiths is a director and the controlling shareholder of both Ora Capital Limited and Cream Capital Limited, which together hold 11,377,044 shares (79% of his reported stake).
• · Each ADS represents three ordinary shares of the issuer.
• · The sales occurred over three days (Aug 10-12, 2026) at prices ranging from $15.58 to $16.35 per ADS.
• · The filing explicitly notes 'significant dilution' from an increase in the issuer's share capital as a contributing factor to the reduced ownership percentage.

14-08-2026

Fermi Inc. appointed Lee McIntire as CEO effective August 11, 2026, with an annual base salary of $750,000, a target bonus of 100% of base salary, and a $3,000,000 restricted stock unit grant under the 2025 LTIP. The appointment follows the company's conversion from Fermi LLC to Fermi Inc. in June 2025. No prior period financial data is provided, so no period-over-period comparisons are available.

• · Mr. McIntire will continue to serve as a director without additional compensation.
• · The RSU award cliff vests on the first anniversary of the grant date, subject to continued employment.
• · Accelerated vesting occurs upon 60 days after successor CEO appointment, change in control without award assumption, termination without cause within 12 months post-change in control, or death/disability.
• · Severance includes unpaid base salary, accrued vacation, vested benefits, and unreimbursed expenses; plus annual bonus for prior year if termination due to death or disability.
• · Mr. McIntire is required to be present at a company facility at least three days per week.

14-08-2026

Federation des caisses Desjardins du Quebec filed its quarterly 13F-HR for the period ending June 30, 2026, reporting total holdings of approximately $32.73 billion across a diversified portfolio of 6190 positions. The filing includes significant holdings in major U.S. and international equities such as Apple ($397.4M), Alphabet ($258.9M), Amazon ($227.8M), and Microsoft (implied by large positions), with a mix of growth and value stocks. No period-over-period comparisons are available as this is a single-period snapshot, but the portfolio shows broad exposure across sectors including technology, healthcare, financials, and industrials.

• · The filing includes 8 other reporting managers: Desjardins Global Asset Management Inc., Desjardins Securities inc., Regime de rentes du Mouvement Desjardins, Desjardins Trust Inc., Desjardins Investments Inc, Desjardins Capital Management Inc, Desjardins Groupe D'assurances Generales Inc, and Desjardins Financial Security Life Assurance Company.
• · All holdings are listed as 'DFND' (defined) and none are on loan.
• · Top holdings by value include Apple ($397.4M), Alphabet Class A ($258.9M), Amazon ($227.8M), Alphabet Class C ($122.7M), and Advanced Micro Devices ($103.8M).
• · The portfolio includes a mix of U.S. common stocks, foreign ordinary shares, and American Depositary Receipts (ADRs).
• · Notable positions include Nu Holdings Ltd. (634,620 shares), AT&T Inc. (1,161,890 shares), and Johnson Controls International (189,841 shares).

14-08-2026

Firsthand Capital Management, Inc. filed its quarterly 13F-HR for the period ending June 30, 2026, reporting a portfolio of 54 equity holdings with a total market value of approximately $62.6 million. The largest positions include Roku Inc. ($8.3M), Bloom Energy Corp ($7.6M), and Rocket Lab Corp ($6.1M), reflecting a focus on technology and clean energy. The portfolio shows a mix of established names and smaller, speculative holdings, with no prior-period data provided for comparison.

• · The portfolio includes 54 equity positions with a total market value of $62,562,405.
• · Top holdings by market value: Roku Inc. ($8,288,400), Bloom Energy Corp ($7,567,500), Rocket Lab Corp ($6,099,000), Coherent Corp ($3,944,700), Oklo Inc ($3,139,800).
• · Smallest positions include Solstice Advanced Materials Inc ($12,847), Orion Energy Systems Inc ($16,366), ARQ Inc ($17,340), ChargePoint Holdings Inc ($17,730).
• · Notable speculative holdings: Domo Inc (250,000 shares, $782,500), Chegg Inc (260,000 shares, $262,600), SunPower Inc (150,000 shares, $103,095).
• · No prior-period data is included in this filing, so period-over-period comparisons are not possible.

14-08-2026

Ilex Capital Partners (UK) LLP filed its quarterly Form 13F-HR for the period ending June 30, 2026, disclosing 147 equity holdings with a total market value of approximately $4.88 billion. The portfolio is concentrated in consumer staples, healthcare, and technology, with top positions in Procter & Gamble ($547.7M), Keurig Dr Pepper ($162.7M), International Flavors & Fragrances ($156.8M), and T-Mobile US ($155.2M). The filing reflects a diversified, large-cap oriented strategy with no single sector dominating.

• · The filing includes 147 equity positions with a total market value of $4,877,642,491.
• · Top 5 holdings by value: Procter & Gamble ($547.7M), Keurig Dr Pepper ($162.7M), International Flavors & Fragrances ($156.8M), T-Mobile US ($155.2M), and Hilton Worldwide ($131.0M).
• · Notable smaller positions include GameStop ($2.9M), Canada Goose ($1.6M), and Vertical Aerospace ($10.4M).
• · The portfolio includes several special purpose acquisition company (SPAC) warrants: Galata Acquisition Corp. II, Leapfrog Acquisition Corp., Range Capital Acquisition Corp. I, and Trailblazer Acquisition Corp.
• · No period-over-period comparisons are available as this is a single snapshot filing.

13-08-2026

Exec. Vice President Robinson Teri was awarded 90,000 Stock Option (right to buy).

• · Exec. Vice President Robinson Teri was awarded 90,000 Stock Option (right to buy)

13-08-2026

SVP, General Counsel Lee Chan Henry sold 2,666 American Depositary Shares at $360.00 (~$960K). 7 transactions reported in total. Lee Chan Henry holds 2,666 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · SVP, General Counsel Lee Chan Henry exercised/converted 812 American Depositary Shares at $194.47 (~$158K)
• · SVP, General Counsel Lee Chan Henry exercised/converted 1,058 American Depositary Shares at $213.32 (~$226K)
• · SVP, General Counsel Lee Chan Henry exercised/converted 796 American Depositary Shares at $159.03 (~$127K)
• · SVP, General Counsel Lee Chan Henry sold 2,666 American Depositary Shares at $360.00 (~$960K)
• · SVP, General Counsel Lee Chan Henry exercised/converted 10,556 Share Option (Right to Buy)
• · SVP, General Counsel Lee Chan Henry exercised/converted 13,754 Share Option (Right to Buy)
• · SVP, General Counsel Lee Chan Henry exercised/converted 10,348 Share Option (Right to Buy)

13-08-2026

BSIV Hold 101, LP and related entities (Bregal Sagemount) disclosed beneficial ownership of 14,252,718 shares of Neptune Insurance Holdings Inc. Class A Common Stock, representing 15.02% of the 94,895,913 shares outstanding as of April 27, 2026. This Schedule 13G/A filing reflects no change in the ownership position from the prior filing, as the percentage remains at 15.02%.

• · The filing is an amendment (Schedule 13G/A) filed on August 13, 2026, with a date of change of August 13, 2026.
• · The beneficial ownership is held directly by BSIV Hold 101, LP, with BSIV Hold 101 GP, LLC as its general partner, Bregal Sagemount IV General Partner Jersey Ltd as its sole member, and Bregal Sagemount Management LP as investment advisor.
• · Gene Yoon, as managing director of Bregal LP, may be deemed to have voting and dispositive power over the shares.
• · The filing is made pursuant to Rule 13d-1(d) under the Securities Exchange Act of 1934.
• · The issuer's principal business address is 400 6th Street S, Suite 2, St. Petersburg, FL 33701.

13-08-2026

Charles E. Young, CEO of Smart Sand, Inc., filed a Schedule 13G/A disclosing beneficial ownership of 7,357,733 shares (17.3%) of the company's common stock as of June 30, 2026. This includes 5,842,700 shares held by Keystone Cranberry, LLC (13.7%), of which Mr. Young owns approximately 67% membership interest and serves as sole managing member, along with 1,184,664 shares held directly and 330,369 restricted shares subject to time vesting. The filing does not indicate any change in ownership from prior filings, as it is an amendment to a previously filed Schedule 13G.

• · The filing is an amendment (Schedule 13G/A) filed on August 13, 2026, with an event date of June 30, 2026.
• · Charles E. Young disclaims beneficial ownership of shares held by Keystone Cranberry, LLC except to the extent of his pecuniary interest.
• · The 500,879 performance-based restricted shares are explicitly excluded from the beneficial ownership calculation.
• · The filing is made under Rule 13d-1(d), indicating the filer is a passive investor not seeking control.

13-08-2026

Chief Executive Officer Schwartz Todd G. bought 60,000 Class A Common Stock at $7.13 (~$428K). Schwartz Todd G. holds 553,733 shares after the transaction.

• · Chief Executive Officer Schwartz Todd G. bought 60,000 Class A Common Stock at $7.13 (~$428K)

13-08-2026

Director Tan Aik Na sold 432 Common Stock at $6.01 (~$2.6K). Tan Aik Na holds 24,968 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Director Tan Aik Na sold 432 Common Stock at $6.01 (~$2.6K)

13-08-2026

Motovance Holdings Limited and its director Li Wang filed a Schedule 13G disclosing beneficial ownership of 422,500 Class A Ordinary Shares of Park Ha Biological Technology Co., Ltd., representing a 9.7% stake. The filing is a passive investment (Rule 13d-1(c)) and follows a reverse stock split and warrant exercises that adjusted the share count. No positive or negative performance metrics are present in this ownership disclosure.

• · The filing is made under Rule 13d-1(c), indicating a passive investment intent.
• · The beneficial ownership calculation is based on 2,297,902 shares outstanding after a reverse stock split on August 6, 2026, plus 2,040,000 shares issued upon warrant exercise.
• · Each Reporting Person disclaims beneficial ownership except to the extent of their pecuniary interest.

13-08-2026

Chief Executive Officer Simpson Stuart was awarded 666,667 Nil Cost Options.

• · Chief Executive Officer Simpson Stuart was awarded 666,667 Nil Cost Options

13-08-2026

President & COO Rozakis Jim had withheld for taxes 4,041 Common Stock at $202.71 (~$819K). This amends a previously filed Form 4. Rozakis Jim holds 282,322 shares after the transaction.

• · President & COO Rozakis Jim had withheld for taxes 4,041 Common Stock at $202.71 (~$819K)

13-08-2026

Director DiTrolio Joseph was awarded 35,000 Common Stock. DiTrolio Joseph holds 308,413 shares after the transaction.

• · Director DiTrolio Joseph was awarded 35,000 Common Stock

13-08-2026

Axim Planning & Wealth filed a Schedule 13G/A with the SEC on August 13, 2026, disclosing beneficial ownership of 7,986,310 Class A Ordinary Shares of EHang Holdings Ltd, representing 5.3% of the outstanding shares. The filing indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · Axim Planning & Wealth is an Ohio-based LLC filing as an investment adviser (IA).
• · The filing is an amendment (SCHEDULE 13G/A) to a prior Schedule 13G.
• · The filer disclaims beneficial ownership of 152,078 shares held by others.
• · The filing certifies the securities were not acquired to change or influence control of EHang.

13-08-2026

Antony P. Ressler filed a Schedule 13G/A with the SEC on August 13, 2026, disclosing beneficial ownership of 109,435,458 shares of Ares Management Corp Class A common stock, representing 33.1% of the outstanding shares as of June 30, 2026. The filing updates his ownership position and details the structure through which shares are held, including a charitable foundation and Ares Owners Holdings L.P.

• · Ressler has sole voting and dispositive power over 2,325,153 shares held by a charitable foundation where he serves as trustee.
• · Shared voting and dispositive power covers 4,281,729 Class A shares and 102,828,576 AOG Units held by Ares Owners.
• · Ares Owners holds 2,235,625 Class A shares and 49,764,375 AOG Units on behalf of Ressler or a vehicle he controls.
• · Ressler expressly disclaims membership in a group with Ares Owners, Ares Partners, and other Board Members under Section 13(d)(3).
• · The filing is an amendment to a previous Schedule 13G, indicating a change in ownership or other required update.

13-08-2026

GOLDMAN SACHS GROUP INC bought 500,000 Common Stock at $17.00 (~$8.5M). 29 transactions reported in total. GOLDMAN SACHS GROUP INC holds 3,020,632 shares after the transaction.

• · GOLDMAN SACHS GROUP INC bought 85,000 Common Stock at $21.00 (~$1.79M)
• · GOLDMAN SACHS GROUP INC sold 988 Common Stock at $22.03 (~$21.8K)
• · GOLDMAN SACHS GROUP INC sold 447 Common Stock at $21.87 (~$9.78K)
• · GOLDMAN SACHS GROUP INC sold 1,332 Common Stock at $22.03 (~$29.3K)
• · GOLDMAN SACHS GROUP INC sold 200 Common Stock at $22.05 (~$4.41K)
• · GOLDMAN SACHS GROUP INC sold 1,556 Common Stock at $22.06 (~$34.3K)
• · GOLDMAN SACHS GROUP INC sold 3,402 Common Stock at $22.02 (~$74.9K)
• · GOLDMAN SACHS GROUP INC sold 200 Common Stock at $22.10 (~$4.42K)

14-08-2026

Nan Shan Life Insurance Co., Ltd. filed its Form 13F-HR for the quarter ended June 30, 2026, disclosing 82 equity holdings with a total market value of approximately $3.19 billion. The portfolio is heavily concentrated in U.S. large-cap technology and healthcare names, with top holdings including Advanced Micro Devices, Alphabet, Amazon, Apple, and Microsoft. The filing reflects a diversified equity portfolio managed by the Taiwan-based insurer.

• · The filing was signed by Brian Tsai, Chief Finance Officer, on August 14, 2026.
• · The portfolio includes 82 positions, with the largest single holding being Advanced Micro Devices at $127.9 million.
• · Notable large positions include Alphabet ($220.0M), Amazon ($112.5M), Apple ($146.3M), Microsoft ($129.4M), and NVIDIA ($130.6M).
• · The portfolio also includes significant holdings in ETFs such as Invesco QQQ Trust ($60.5M), iShares Core MSCI Emerging Markets ETF ($18.7M), and Vanguard S&P 500 ETF ($41.2M).
• · All reported shares are held with sole voting and dispositive power, except for Global X Robotics & AI ETF (234,000 shares with sole dispositive but no voting power), Vanguard S&P 500 ETF (60,032 shares with sole dispositive but no voting power), and Vanguard Utilities ETF (150,369 shares with sole dispositive but no voting power).

14-08-2026

ENTREWEALTH, LLC filed its quarterly 13F-HR report for the period ending June 30, 2026, disclosing total holdings of approximately $269.9 million across 140 positions. The portfolio is heavily weighted toward ETFs, with significant positions in Dimensional ETF Trust, SPDR Series Trust, and Simplify Exchange Traded Funds. Notable individual stock holdings include Apple, Microsoft, NVIDIA, and Alphabet.

• · Top holdings include Dimensional ETF Trust US Core Equity Market ETF ($27.2M), Dimensional ETF Trust National Municipal Bond ETF ($11.2M), Simplify Exchange Traded Funds US Equity Plus Convexity ($11.9M), PIMCO Equity Series RAFI Dynamic Multi-Factor US Equity ($10.1M), and Dimensional ETF Trust Emerging Markets Core Equity ($10.7M).
• · Largest individual stock positions: Apple ($4.0M), NVIDIA ($3.4M), Microsoft ($2.5M), Alphabet Class A ($1.1M), Alphabet Class C ($1.2M), Amazon ($1.4M), and Meta ($0.7M).
• · The portfolio includes a mix of equity ETFs, fixed income ETFs, and alternative ETFs such as gold and bitcoin-related products.
• · All positions are reported as sole voting and investment discretion, with no shared or non-discretionary holdings.

14-08-2026

Oasis Management Co Ltd. filed its quarterly 13F-HR for the period ending June 30, 2026, reporting total holdings valued at approximately $1.88 billion across 108 positions. The fund's top holdings include Invesco QQQ Trust put options ($662.8M), Vail Resorts ($317.1M), and Applied Digital ($186.8M), with significant exposure to technology, Chinese ADRs, and special situation equities. The filing shows a concentrated portfolio with large put option positions on major ETFs, indicating a hedging or bearish tilt on broad market indices.

• · The fund holds put options on Invesco QQQ Trust (900,000 shares notional) and iShares MSCI Japan ETF (1,500,000 shares notional), indicating a bearish or hedging stance on US tech and Japanese equities.
• · The largest single equity position is Vail Resorts at $317.1M (2,329,018 shares), representing about 16.9% of the total portfolio.
• · The fund holds a significant call option on CoreWeave (1,250,700 shares, $124.5M), suggesting a bullish view on AI infrastructure.
• · Chinese ADR exposure is substantial, including Alibaba notes ($59.0M), RLX Technology ($12.3M), GDS Holdings ($17.4M), VNET Group ($27.7M), and several others.
• · The portfolio includes many small-cap and micro-cap positions, particularly in warrants and special situation equities, indicating an event-driven or distressed strategy.
• · Notable new or increased positions include Applied Digital ($186.8M), Core Scientific ($30.7M), and Hut 8 ($31.4M), reflecting a focus on Bitcoin mining and AI data center plays.
• · The fund holds a large position in USA Today Co Inc. ($26.3M, 3,078,562 shares), a legacy media company.
• · Positions in Ferrari N.V. put options ($22.3M) and Stratus Properties ($27.6M) add to the hedging and real estate exposure.

14-08-2026

Osisko Gold Group Inc. filed a Form 6-K with the SEC for the month of August 2026, attaching a press release dated August 13, 2026. The filing is a routine foreign private issuer report and contains no financial figures or operational details.

14-08-2026

21Shares Ethereum ETF (TETH) reported a net decrease in net assets of $4.1M for Q2 2026 and $12.1M for H1 2026, driven by significant realized and unrealized losses on its ether holdings. While the fund generated $27,730 in staking rewards in Q2 (vs. $0 in Q2 2025), net investment income turned positive to $20,797 from a loss of ($9,583) a year ago. However, total net assets fell sharply to $12.9M from $31.3M at year-end 2025, and NAV per share dropped to $7.88 from $14.83, reflecting the decline in ether prices and redemption activity.

• · The fund had no liabilities at either period end.
• · Total ether holdings decreased from 8,685.3821 to 8,185.4684 during Q2 2026, a net reduction of about 5.8%.
• · Ether redemptions totaled 10,835.1655 ether in Q2 2026, while purchases were 10,335.0903 ether.
• · Staking rewards received in Q2 2026 were 13.3463 ether.
• · The fund's accumulated earnings swung from a surplus of $5.8M at Dec 31, 2025 to a deficit of ($6.4M) at Jun 30, 2026.
• · Sponsor fee was fully waived in Q2 2026 ($9,657 waiver vs. $9,657 expense), compared to no waiver in Q2 2025.
• · Net realized loss on ether sold for redemptions was $3.6M in Q2 2026 and $12.8M in H1 2026.
• · Net change in unrealized depreciation on ether was ($445,355) in Q2 2026, versus an appreciation of $6.5M in Q2 2025.

14-08-2026

Balyasny Asset Management L.P. and related entities disclosed a 5.93% beneficial ownership stake in Sagimet Biosciences Inc. as of June 30, 2026, holding 3,626,113 shares of common stock. The filing is a routine Schedule 13G by a passive investment manager, indicating no intent to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(b), confirming the shares were acquired in the ordinary course of business and not to change or influence control.
• · Balyasny entities have sole voting and dispositive power over all 3,626,113 shares.
• · Atlas Diversified Master Fund, Ltd. directly holds 1,126,113 shares, and Atlas Private Holdings (Cayman) Ltd directly holds 2,500,000 shares.

14-08-2026

Balyasny Asset Management L.P. and related entities disclosed a 6.35% beneficial ownership stake in SkyWater Technology, Inc., holding 3,122,552 shares of common stock as of June 30, 2026. The filing is a routine Schedule 13G by an institutional investment manager, indicating passive investment intent. No negative or flat metrics are present in this filing.

• · The filing is made under Rule 13d-1(b), indicating the securities were acquired in the ordinary course of business and not to change or influence control.
• · Balyasny Asset Management L.P. serves as the investment manager for Atlas Diversified Master Fund, Ltd., which directly holds the shares.
• · Each reporting person disclaims beneficial ownership except to the extent of their pecuniary interest.

14-08-2026

Atairos Partners GP, Inc. filed its quarterly 13F-HR for the period ending June 30, 2026, disclosing holdings in Advantage Solutions Inc. (Class A) and Clarivate Plc (ordinary shares). The fund reported 439,430 shares of Advantage Solutions and 10,232,667 shares of Clarivate, all held with sole voting and dispositive power. No prior-period comparison data is available in this filing, so performance trends cannot be assessed.

• · All shares are held with sole voting and dispositive power (DFND).
• · Filing is a 13F combination report for Atairos Partners GP, Inc. and Atairos Group, Inc.

14-08-2026

Balyasny Asset Management L.P. and related entities filed a Schedule 13G/A with the SEC on August 14, 2026, disclosing beneficial ownership of 4,662,039 shares of Rezolute, Inc. (RZLT) common stock, representing approximately 4.84% of the 96,292,331 shares outstanding as of May 8, 2026. The shares are held directly by Atlas Diversified Master Fund, Ltd., an investment management client of Balyasny. The filing indicates the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b), indicating the filer is a passive investor.
• · Balyasny Asset Management L.P. serves as the investment manager of Atlas Diversified Master Fund, Ltd., which directly holds the shares.
• · Each of the Reporting Persons has sole voting and dispositive power over the 4,662,039 shares.
• · Atlas Diversified Master Fund, Ltd. has the right to receive dividends and proceeds from the sale of the reported securities.
• · The filing was made on August 14, 2026, with a date of change as of June 30, 2026.

14-08-2026

Balyasny Asset Management L.P. and related entities disclosed a 9.45% beneficial ownership stake in SAB Biotherapeutics, Inc. as of June 30, 2026, holding 7,225,439 shares (including 3,465,000 shares issuable upon warrant exercise). The filing is an amendment to Schedule 13G, indicating the position was acquired in the ordinary course of business and not for control purposes. The stake is subject to a 9.99% beneficial ownership limitation on warrant exercises.

• · The filing is an amendment (SC 13G/A) dated August 14, 2026, with a date of change of August 14, 2026.
• · The beneficial ownership is reported by five entities: Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC, and Dmitry Balyasny.
• · The shares are held through two investment management clients: Atlas Diversified Master Fund, Ltd. (1,450,439 shares) and Atlas Private Holdings (Cayman) Ltd. (2,310,000 shares plus 3,465,000 from warrants).
• · The warrants have a blocker preventing exercise if it would result in beneficial ownership exceeding 9.99% of outstanding shares.
• · All reporting persons have sole voting and dispositive power over the 7,225,439 shares.
• · The filing certifies the securities were acquired in the ordinary course of business and not to change or influence control.

14-08-2026

Super Hi International Holding Ltd. filed a Form 6-K with the SEC on August 14, 2026, reporting a Board Meeting outcome. The filing includes an exhibit (99.1) detailing the date of the board meeting, but no specific financial results or operational metrics were disclosed in this report.

• · The filing is a Form 6-K for the month of August 2026.
• · Commission File Number: 001-42101.
• · The registrant's principal executive offices are at 1 Paya Lebar Link, #09-04 PLQ 1 Paya Lebar Quarter, Singapore 408533.
• · The report was signed by Ping Shu, Director and Chairperson.

14-08-2026

Balyasny Asset Management L.P. and related entities filed a Schedule 13G/A with the SEC on August 14, 2026, disclosing that they beneficially own 0% of Rallybio Corp's common stock, representing 0 shares. The filing indicates that the Reporting Persons would not be deemed to have beneficial ownership of any shares, based on 5,298,137 shares outstanding as of May 8, 2026. This represents a complete exit from any prior position, though no prior ownership level is disclosed in this filing.

• · The filing is an amendment (SC 13G/A) to a prior Schedule 13G, indicating a change in ownership.
• · Balyasny Asset Management L.P. is an investment adviser (IA) and the filing is made under Rule 13d-1(b).
• · The Reporting Persons include BAM GP LLC (General Partner of BAM), Balyasny Asset Management Holdings LP (Sole Member of BAM GP), Dames GP LLC (General Partner of BAM Holdings), and Dmitry Balyasny (Managing Member of Dames).
• · All Reporting Persons disclaim beneficial ownership of the shares.
• · The filing certifies that the securities were acquired and are held in the ordinary course of business and not for changing or influencing control of the issuer.

14-08-2026

Balyasny Asset Management L.P. and related entities filed a Schedule 13G disclosing beneficial ownership of 97,699 shares of Quince Therapeutics, Inc. (QNCX), representing approximately 9.99% of the outstanding common stock as of June 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to influence control. The beneficial ownership includes shares held through managed funds and is subject to a 9.99% blocker on warrants and preferred shares.

• · The filing is a Schedule 13G (passive investment), not a 13D (activist intent).
• · The beneficial ownership includes 69,281 common shares held by Atlas Diversified Master Fund, Ltd., and 28,418 shares issuable upon exercise of warrants and preferred shares (subject to a 9.99% blocker).
• · The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.
• · The filing date is August 14, 2026, with the event date as of June 30, 2026.

14-08-2026

Azul S.A. reported record 2Q26 operating revenue of R$4,978.7 million (+0.7% YoY), driven by higher fares and yields despite a 10.6% capacity reduction. However, EBITDA plunged 55.4% to R$510.1 million and the company swung to a net loss of R$1,041.2 million, pressured by a 61.8% surge in fuel costs and a 26.0% rise in unit costs. Total debt fell R$13.0 billion to R$21.4 billion following the completion of its financial restructuring, with net leverage down to 3.0x.

• · Passenger revenue in 2Q26 was R$4,560.5M, down 0.4% YoY, while cargo revenue and other grew 15.1% to R$418.1M.
• · Aircraft fuel expense rose 41.2% YoY to R$1,960.8M in 2Q26.
• · Sales and marketing expenses increased 64.1% YoY in 2Q26.
• · Adjusted net loss widened 125.1% YoY to R$1,070.9M in 2Q26.
• · Financial result swung to a loss of R$882.2M in 2Q26 from a gain of R$913.5M in 2Q25.
• · Net leverage using immediate liquidity was 2.8x as of quarter-end.
• · Depreciation and amortization fell 12.3% YoY due to lease modifications from restructuring.
• · Average exchange rate weakened 10.9% YoY to R$5.05 per USD in 2Q26.

14-08-2026

Balyasny Asset Management L.P. and related entities disclosed beneficial ownership of 500,000 Class A common shares of Research Alliance Corp III, a blank check company, representing approximately 6.43% of shares outstanding as of June 30, 2026. The shares are held directly by Atlas Diversified Master Fund, Ltd., an investment management client of BAM, and the filing is made under Rule 13d-1(b), indicating passive investment intent. No changes in ownership or control are indicated.

• · The shares are held directly by Atlas Diversified Master Fund, Ltd., a Cayman Islands exempted company and investment management client of BAM.
• · Each Reporting Person has sole power to vote and dispose of the 500,000 shares.
• · The filing is made under Rule 13d-1(b), indicating the securities were acquired in the ordinary course of business and not to change or influence control of the issuer.
• · The Reporting Persons include a chain of entities: BAM GP is the General Partner of BAM, BAM Holdings is the Sole Member of BAM GP, Dames is the General Partner of BAM Holdings, and Dmitry Balyasny is the Managing Member of Dames.

14-08-2026

Saudi Electronic Games Holding Co filed its quarterly 13F-HR for the period ending June 30, 2026, disclosing a single equity holding: 11,414,680 shares of Take-Two Interactive Software (NASDAQ: TTWO) valued at approximately $2.85 billion. The filing reflects a passive investment strategy with no options or other derivatives reported.

• · The filing is a 13F-HR for the quarter ended June 30, 2026, filed on August 14, 2026.
• · The sole holding is Take-Two Interactive Software (CUSIP: 874054109), with 11,414,680 shares.
• · The investment is classified as 'DFND' (defined as discretionary) and is held in a non-US account.
• · No other securities, options, or convertible instruments were reported.

14-08-2026

Balyasny Asset Management L.P. and related entities filed a Schedule 13G/A disclosing beneficial ownership of 9,313,341 shares of Ovid Therapeutics Inc. common stock, representing 4.99% of shares outstanding as of June 30, 2026. The filing includes 2,594,265 shares issuable upon exercise of warrants subject to beneficial ownership limitations. The stake is held in the ordinary course of business and not for changing or influencing control of the issuer.

• · The filing is an amendment (13G/A) filed on August 14, 2026, with a date of event change of August 14, 2026.
• · Balyasny Asset Management L.P. is the investment manager for both Atlas Diversified Master Fund, Ltd. and Atlas Private Holdings (Cayman) Ltd.
• · The beneficial ownership is subject to two separate blockers: 4.99% for Series B Warrants and 9.99% for Prefunded Warrants.
• · Each reporting person has sole power to vote and dispose of all 9,313,341 shares.
• · The filing certifies the securities were acquired in the ordinary course of business and not to change or influence control.

14-08-2026

Balyasny Asset Management L.P. and related entities filed an amended Schedule 13G disclosing beneficial ownership of 1,169,910 shares of Nasus Pharma Ltd. common stock, representing approximately 9.99% of shares outstanding. The position includes 898,473 shares and 271,437 shares issuable upon exercise of warrants, subject to a 9.99% beneficial ownership limitation. The filing indicates the shares are held in the ordinary course of business and not for control purposes.

• · The filing is an amendment (13G/A) filed on August 14, 2026.
• · The beneficial ownership is held through Atlas Private Holdings (Cayman) Ltd., an investment management client of BAM.
• · The warrants are subject to a blocker preventing exercise if it would result in beneficial ownership exceeding 9.99%.
• · The Reporting Persons have sole voting and dispositive power over all 1,169,910 shares.

14-08-2026

Balyasny Asset Management L.P. and related entities disclosed a 5.18% beneficial ownership stake in Neurogene Inc. as of June 30, 2026, holding 818,706 shares of common stock. The filing is a routine Schedule 13G by an institutional investment manager, indicating passive investment intent. No positive or negative performance metrics are present in this filing.

• · The filing is made under Rule 13d-1(b), indicating the securities were acquired in the ordinary course of business and not to change or influence control of the issuer.
• · Balyasny Asset Management L.P. serves as the investment manager for Atlas Diversified Master Fund, Ltd., which directly holds the 818,706 shares.
• · Each of the reporting persons has sole power to vote or direct the vote and sole power to dispose or direct the disposition of all 818,706 shares.